Mereo BioPharma Provides Regulatory Updates on Alvelestat
Mereo BioPharma Group plc (MREO) today announced regulatory feedback following recent end-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and the European Medicines...
Buy
or
Mereo BioPharma ADR News & Analysis
-
-
Mereo BioPharma to Participate in Fireside Chat at the SVB Securities Global Biopharma Conference
LONDON, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ:MREO) ("Mereo" or the "Company"), a clinical-stage biopharmaceutical company focused on rare diseases and...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.13%
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Telecoms, Technology and Consumer Services sectors propelled shares higher while losses in the Oil & Gas,...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.41%
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Oil & Gas, Utilities and Financials sectors propelled shares lower. At the close in NYSE, the Dow Jones...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.37%
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Consumer Services, Technology and Financials sectors propelled shares higher. At the close in NYSE, the...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
